The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2020

Filed:

Aug. 14, 2017
Applicant:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Inventors:

Wensheng Yu, Edison, NJ (US);

Ling Tong, Warren, NJ (US);

Joseph A. Kozlowski, Princeton, NJ (US);

Craig A. Coburn, Seattle, WA (US);

De-Yi Yang, Morris Plains, NJ (US);

Deyou Sha, Yardley, PA (US);

Jae-Hun Kim, Scotch Plains, NJ (US);

Michael Dwyer, Scotch Plains, NJ (US);

Kartik M Keertikar, East Windsor, NJ (US);

Bin Hu, Shanghai, CN;

Bin Zhong, Shanghai, CN;

Jinglai Hao, Shanghai, CN;

Dahai Wang, Shanghai, CN;

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/04 (2006.01); A61K 31/5365 (2006.01); C07D 519/00 (2006.01); C07D 513/04 (2006.01); A61K 45/06 (2006.01); A61P 31/12 (2006.01); A61P 31/22 (2006.01); A61P 31/14 (2006.01); A61K 31/4995 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5365 (2013.01); A61K 31/4995 (2013.01); A61K 45/06 (2013.01); A61P 31/12 (2018.01); A61P 31/14 (2018.01); A61P 31/22 (2018.01); C07D 498/04 (2013.01); C07D 513/04 (2013.01); C07D 519/00 (2013.01);
Abstract

The present invention relates to novel Heterocycle-Substituted Tetracyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, A', RRand Rare as defined herein. The present invention also relates to compositions comprising at least one Heterocycle-Substituted Tetracyclic Compound, and methods of using the Heterocycle-Substituted Tetracyclic Compounds for treating or preventing HCV infection in a patient.


Find Patent Forward Citations

Loading…